Recall of Sure Lubricated Condoms Dotted

The Pharmacy and Poisons Board (PPB) in collaboration with the National STI and AIDS Control Program (NASCOP) conducted a joint post-market surveillance quality survey of selected medical products and health technologies used in Kenya. Among the products that were sampled and tested were male latex condoms. The laboratory analysis results indicated that the following male latex condoms failed to comply with specification (s) for ISO 4074:2015 standard


NAIROBI, Kenya September 25, 2019 - The Pharmacy and Poisons Board today celebrated the World Pharmacists Day under the theme “Safe and Effective Medicines for All,” with a launch of three key pharmaceutical guidelines.

Medicines Track System Underway

Nairobi, KENYA July 23, 2019 -The Pharmacy and Poisons Board (PPB) is currently working on medicines track and trace system that will ensure that all medical products and health technologies in the market have a tracing number. 

NDS for Licit Control Moves to Production

The Pharmacy and Poisons Board is happy to announce the migration of National Drug Control System (NDS) for Licit control from test environment to production. This System is used to control Narcotics, Psychotropics, and Precursor Chemical substances globally.

Herbal clinics in the limelight for substandard medicine production

The Pharmacy and Poisons Board (PPB) yesterday seized herbal medicines and personnel working at three herbal clinics in Nairobi over substandard medicines.


The board that did inspection at Murugu Herbal Clinic and two other clinics within Nairobi, was checking for the quality of the herbal medicines produced, confirming the licensing of the clinic and how the medicines are produced from the beginning of the manufacturing process to the end.

Mid-Term Review Strategy Retreat

Dr. Jackson Kioko opens mid-term review strategy retreat at Savora Whitesands Hotel

Kenya Endorsed as a Member Economy to the AHWP at the 22nd Asian Harmonization Working Party(AHWP) i

Medical devices including In vitro diagnostics constitute a vital component of health products and health technologies that contribute to the attainment of the highest standards of health for all citizens as envisioned in Article 43 of the Constitution of Kenya. Regulation of these products is key to attainment of this Human Right.

Pharmacy Regulator goes big on Sh240M automation project

The Pharmacy and Poisons Board (PPB)  has fully automated services, making it the first national drug regulatory authority in Africa to automate clinical trial registry process among other services.


The Pharmacy and Poisons Board (PPB) is concerned over the high level of self-medication among the general public.

Be safe buy medicines from licensed pharmacy

Everyone knows that it is impossible to buy health. But you can buy medicines that can help to improve your health


Medicines help us live longer and healthier. They can help cure, treat an illness or disease and can also prevent some conditions from developing
During the course of our lives, it is likely that we will all need to take medicines. These might include vaccines to prevent illness or prescription medicines to treat serious infections.

Ensuring safe use of medicines

The most important step to medication safety is to educate yourself about the specific drugs you and your family are taking and the conditions they are intended to treat. Medications are intended to make you better, but they can cause harm if they are used or stored improperly. Some side effects are mild like an upset stomach while others can be more serious like liver damage.


According to the World Health Organization's (WHO), self-medication is defined as the use of drugs to treat self-diagnosed disorders or symptoms, or the intermittent or continued use of a prescribed drug for chronic or recurrent diseases or symptoms.

Parallel importation of drugs to lower cost of medication

Recently, the Pharmacy and Poisons Board of Kenya made a bold decision to address what maybe the local pharmaceutical industry’s most controversial issue, parallel trade in pharmaceuticals. While there have been previous attempts to tackle this matter in the past, it is hoped that the current attempt will pay attention to all important aspects of this issue in order to build a consensus among all interested parties in coming up with a policy position that is not only widely acceptable but also addresses most of the contentious issues once and for all. 

Managing pharmaceutical risks in cross border healthcare

We live in a dramatically transforming world with huge implications for health, medicine and the role of the regulators. While, there are many benefits of globalization, there can be no doubt that with the increasing interconnectedness of the world, comes new vulnerabilities to a range of serious even catastrophic health threats.